GSK plc
European markets fall over 1% as investors await UK budget; Campari shares slide 15%
Novo Nordisk shares fall to nine-month low Novo Nordisk shares on Wednesday fell to levels last seen in January of 2024 according to LSEG data, pulling back after competitor Eli Lilly posted weaker-than-expected quarterly results. Eli Lilly missed expectations for profit and revenue in the third quarter and cut its adjusted profit guidance for the […]
Read More
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing […]
Read More
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon! Wegovy, […]
Read More
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. […]
Read More
Want to cash in on India’s growth? Veteran investor names 5 ‘well-run’ companies to buy right now
Interest in India has been rising steadily among investors, thanks to its growing economy , strong stock market performance and burgeoning population . Amid some talk of an Indian stock market bubble , however, Pramod Gubbi, co-founder of Marcellus Investment Managers, revealed how he is playing the market. The veteran investor said he is focused […]
Read More
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred international revenue into 2025. The biotech company now expects 2024 product revenue to come in between $3 billion to $3.5 […]
Read More
These stocks will be the winners and losers of rising U.S.-China trade tensions, Wall Street says
Tensions are ratchetting up between U.S. and its major trading partners. In the latest, Bloomberg on Wednesday reported that the Biden administration is considering a wide-sweeping rule to clamp down on companies exporting their critical chipmaking equipment to China. That follows new tariff rates on $18 billion worth of Chinese imports — including electric vehicles, […]
Read More
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC. A day earlier, the pharmaceutical giant’s stock had closed 6% higher after its […]
Read More
Stocks earning the major moves premarket: Walgreens, Levi Strauss, Micron and more
Verify out the corporations making headlines prior to the bell. Micron — Shares slipped almost 6% just after the semiconductor manufacturer posted earnings assistance of $7.6 billion for its existing quarter, coming in line with analyst expectations. Micron also claimed a 3rd-quarter earnings and earnings defeat. GSK — Shares of the biopharmaceutical organization slid virtually […]
Read More
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said. Merck’s shot, called Capvaxive, specifically protects against 21 strains […]
Read More